There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (3)

Short Titles

Short Titles - House of Representatives

Short Titles as Introduced

Price Relief, Innovation, and Competition for Essential Drugs Act

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To amend the Public Health Service Act to shorten the exclusivity period for brand name biological products from 12 to 7 years.

Actions Overview (1)

07/26/2018Introduced in House

All Actions (3)

07/27/2018Referred to the Subcommittee on Health.
Action By: Committee on Energy and Commerce
07/26/2018Referred to the House Committee on Energy and Commerce.
Action By: House of Representatives
07/26/2018Introduced in House
Action By: House of Representatives

Cosponsors (0)

No cosponsors.

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
House Energy and Commerce07/26/2018 Referred to
House Energy and Commerce Subcommittee on Health07/27/2018 Referred to

No related bill information was received for H.R.6577.

Subjects (1)

Latest Summary (0)

A summary is in progress.